The MCP-1 -2518 A/G polymorphism is not a susceptibility factor for chronic pancreatitis

Pancreatology

Volumn 6, Issue 4, 2006, Pages 297-300

  Sass, David A ^a   Papachristou, Georgios I ^a   Lamb, Janette ^a   Barmada, M Michael ^a   Brand, Randall E ^c   Money, Mary E ^d   Hawes, Robert H ^e   Cotton, Peter B ^e   Slivka, Adam ^a   Whitcomb, David C ^a,b,f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^d Washington County Hospital   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Chronic pancreatitis; Fibrosis; Genetics; Inflammation; Monocyte chemotactic protein 1

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

EID: 33748306141     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000092692     Document Type: Article

References (25)

1. Etemad B, Whitcomb DC: Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001;120: 682-707.
2. Ammann RW, Heitz PU, Kloppel G: Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology 1996;111:224-231.
3. Ammann RW, Muellhaupt B: Progression of alcoholic acute to chronic pancreatitis. Gut 1994;35:552-556.
4. Whitcomb DC: Value of genetic testing in management of pancreatitis. Gut 2004;53: 1710-1717.
5. Whitcomb DC: Advances in understanding the mechanisms leading to chronic pancreatitis. Nat Clin Practice Gastro-Hepatol 2004;1: 46-52.
6. Rovin BH, Lu L, Saxena R: A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999;259:344-348.
7. Papachristou GI, Sass DA, Avula H, Lamb J, Lokshin A, Barmada MM, et al: Is the monocyte chemotactic protein-1 -2518 G allele a risk factor for severe acute pancreatitis? Clin Gastroenterol Hepatol 2005;3:475-481.
8. Adams DH, Lloyd AR: Chemokines: leukocyte recruitment and activation cytokines. Lancet 1997;349:490-495.
9. Muhlbauer M, Bosserhoff AK, Hartmann A, Thasler WE, Weiss TS, Herfarth H, et al: A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 2003;125:1085-1093.
10. Szalai C, Kozma GT, Nagy A, Bojszko A, Krikovszky D, Szabo T, et al: Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 2001;108:375-381.
11. Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, Nunez-Roldan A: MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosis. Tissue Antigens 2001;58:335-338.
12. Herfrath H, Goke M, Hellerbrand C, Muhlbauer M, Vogl D, Scholmerich J, et al: Polymorphism of monocyte chemoattractant protein-1 in Crohn's disease. Int J Colorectal Dis 2003;18:401-405.
13. Szalai C, Duba J, Prohaszka Z, Kalina A, Szabo T, Nagy B, et al: Involvement of polymorphisms in the chemokine system in susceptibility for coronary artery disease (CAD). Coincidence of Lp(a) and MCP-1 -2518G/G genotype in CAD patients. Atherosclerosis 2001;158:233-239.
14. Grady T, Liang P, Ernst SA, Logsdon CD: Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis. Gastroenterology 1997;113: 1966-1975.
15. Yang BM, Demaine AG, Klingsnorth A: Chemokines MCP-1 and RANTES in isolated rat pancreatic acinar cells treated with CCK and ethanol in vitro. Pancreas 2000;21:22-31.
16. Deng X, Wang L, Elm MS, Gabazadeh D, Diorio GJ, Eagon PK, et al: Chronic alcohol consumption accelerates fibrosis in response to cerulein-induced pancreatitis in rats. Am J Pathol 2005;166:93-106.
17. Rau B, Baumgart K, Kruger CM, Schilling M, Beger HG: CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications. Intens Care Med 2003;29:622-629.
18. Inoue M, Ino Y, Gibo J, Ito T, Hisano T, Arita Y, et al: The role of monocyte chemoattractant protein-1 in experimental chronic pancreatitis model induced by dibutyltin dichloride in rats. Pancreas 2002;25:e64-e70.
19. Saurer L, Reber P, Schaffner T, Buchler MW, Buri C, Kappeler A, et al: Differential expression of chemokines in normal pancreas and in chronic pancreatitis. Gastroenterology 2000; 118:356-367.
20. Pfützer RH, Barmada MM, Brunskil APJ, Finch R, Hart PS, Neoptolemos J, et al: SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615-623.
21. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N: Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-442.
22. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, et al: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nature Genetics 1996;14:141-145.
23. Gorry MC, Gabbaizedeh D, Furey W, Gates LK Jr, Preston RA, Aston CE, et al: Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997;113:1063-1068.
24. Cardon LR, Bell JI: Association study designs for complex diseases. Nat Rev Genet 2001;2: 91-99.
25. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG: Genetic associations in large versus small studies: an empirical assessment. Lancet 2003;361:567-571.